Ocular Therapeutix Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +55.2% | +113.8% | -4.1% | -5.2% | -6.6% | -11.4% | +11.2% | -9.0% | +96.7% | -9.3% | -8.4% | |
| – | +64.4% | +123.8% | -4.1% | -5.1% | -6.8% | -12.1% | +11.8% | -10.7% | +102.1% | -9.7% | -8.7% | |
| – | +77.1% | +146.6% | -4.8% | -7.1% | -8.2% | -10.8% | +11.9% | -11.9% | +113.8% | -9.5% | -10.2% | |
| – | +77.1% | +146.6% | -4.8% | -7.1% | -8.2% | -10.8% | +11.9% | -11.9% | +113.8% | -9.5% | -10.2% | |
| – | +11.0% | +1.4% | +13.9% | +0.0% | +7.1% | -22.1% | +20.6% | +1.2% | -0.4% | -20.6% | +24.3% | |
| – | +2.1% | +11.7% | -1.0% | -5.6% | +26.4% | +7.5% | -7.0% | +14.8% | +2.2% | +4.9% | +2.4% | |
| – | +4.1% | -18.6% | +6.4% | -0.8% | +3.1% | -1.8% | +3.9% | +5.0% | +0.7% | -1.8% | +0.2% | |
| – | -0.5% | -30.4% | +23.4% | +21.3% | +13.7% | -8.3% | +13.2% | +14.8% | +3.1% | -6.1% | +3.1% | |
| – | -15.5% | -2.8% | +7.4% | +3.7% | +12.6% | +11.5% | +21.8% | +5.2% | +2.0% | +12.5% | -1.5% | |
| – | +10.2% | +47.0% | -42.8% | +8.5% | +4.4% | +10.8% | +27.3% | +6.3% | -33.6% | +93.2% | -12.8% | |
| – | +1.4% | -11.3% | +1.0% | +1.0% | +1.0% | +1.0% | +1.0% | +1.0% | +1.0% | +1.0% | +1.0% | |
| – | +1,060.5% | +347.7% | -7.4% | -6.8% | -10.4% | -15.7% | +15.0% | -15.6% | +153.4% | -11.1% | -10.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +27.8% | +21.3% | +25.6% | +0.7% | +0.6% | +0.8% | +1.9% | +6.6% | +21.2% | +0.5% | +0.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.